SCHEMBL3142853

SCHEMBL3142853

CN(C(=O)c1cccnc1Oc1cc(Cl)ccc1Cl)c1ncccc1Cl

nearest known ligand 0.54

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
GPBAR1 Q8TDU6 12/20 0.54
CYP2C9 P11712 3/20 0.46
CYP3A4 P08684 2/20 0.46
RAB9A P51151 1/20 0.43
CYP1A2 P05177 2/20 0.40
CYP2D6 P10635 2/20 0.40
CYP2C19 P33261 2/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
L3MBTL1 Q9Y468 2/20 0.40
PKM P14618 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
MAPK8 P45983 1/20 0.39
MAPK1 P28482 1/20 0.39
ALDH1A1 P00352 1/20 0.38
POLB P06746 1/20 0.38
GAA P10253 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3146348 0.87 GPBAR1 (0.70) GPBAR1CYP2C9CYP3A4RAB9ACYP1A2
SCHEMBL3141314 0.87 GPBAR1 (0.60) GPBAR1CYP2C9CYP3A4RAB9ACYP1A2
SCHEMBL3137908 0.86 GPBAR1 (0.72) GPBAR1CYP2C9CYP3A4RAB9AMEN1
SCHEMBL3150474 0.85 GPBAR1 (0.63) GPBAR1CYP2C9CYP3A4RAB9ACYP1A2
SCHEMBL3142838 0.84 GPBAR1 (0.56) GPBAR1CYP2C9CYP3A4RAB9ACYP1A2
SCHEMBL3141299 0.84 GPBAR1 (0.58) GPBAR1CYP2C9CYP3A4RAB9ACYP1A2
SCHEMBL3141517 0.84 GPBAR1 (0.63) GPBAR1CYP2C9CYP3A4RAB9ACYP1A2
SCHEMBL3137865 0.84 GPBAR1 (0.63) GPBAR1CYP2C9CYP3A4RAB9ACYP1A2
SCHEMBL3141516 0.84 GPBAR1 (0.58) GPBAR1CYP2C9CYP3A4RAB9ACYP1A2
SCHEMBL3145164 0.83 GPBAR1 (0.58) GPBAR1CYP2C9CYP3A4RAB9ACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8309734-B2 Substituted pyridines as GPBAR1 agonists HOFFMANN-LA ROCHE INC. (US) 2012-11-13 US claimed
US-20100105906-A1 NOVEL PHENYL AMIDE OR PYRIDYL AMIDE DERIVATIVES F. HOFFMANN-LA ROCHE AG, A SWISS COMPANY (CH) 2010-04-29 US claimed
US-8309734-B2 Substituted pyridines as GPBAR1 agonists HOFFMANN-LA ROCHE INC. (US) 2012-11-13 US disclosed
US-8309734-B2 Substituted pyridines as GPBAR1 agonists HOFFMANN-LA ROCHE INC. (US) 2012-11-13 US disclosed
US-8309734-B2 Substituted pyridines as GPBAR1 agonists HOFFMANN-LA ROCHE INC. (US) 2012-11-13 US disclosed
US-20100105906-A1 NOVEL PHENYL AMIDE OR PYRIDYL AMIDE DERIVATIVES F. HOFFMANN-LA ROCHE AG, A SWISS COMPANY (CH) 2010-04-29 US disclosed
US-20100105906-A1 NOVEL PHENYL AMIDE OR PYRIDYL AMIDE DERIVATIVES F. HOFFMANN-LA ROCHE AG, A SWISS COMPANY (CH) 2010-04-29 US disclosed
US-20100105906-A1 NOVEL PHENYL AMIDE OR PYRIDYL AMIDE DERIVATIVES F. HOFFMANN-LA ROCHE AG, A SWISS COMPANY (CH) 2010-04-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100105906-A1 NOVEL PHENYL AMIDE OR PYRIDYL AMIDE DERIVATIVES GPBAR1, GPR119, GLP1R GPBAR1 1/4885CYP2C9 1256/4885CYP3A4 1330/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.